Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1136/bmj.331.7525.1144-c

Type

Journal article

Journal

BMJ (Clinical research ed.)

Publication Date

11/2005

Volume

331

Pages

1144 - 1145

Keywords

Humans, Rare Diseases, Orphan Drug Production, Cost-Benefit Analysis, State Medicine, United Kingdom